companydata.dkcompanydata.dk

UNIKUM Therapeutics ApS: Financial statements 2024

CVR: 41192925

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

UNIKUM Therapeutics ApS (CVR 41192925) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -7,368,177 and a net result of DKK -13,797,011 compared with DKK -14,870,759 the year before. Equity in the 2024 report amounted to DKK -4,820,957. The company had 9 employees in the financial year.

Gross Profit
DKK -7,368,177
Profit/Loss
DKK -13,797,011
Equity
DKK -4,820,957
Total Assets
DKK 3,758,761
Employees
9

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--7.4M-13.8M-4.8M9
2023--7.5M-14.9M-16.3M9
2022--3.3M-7.6M-15.3M7
2021--2.7M-5.6M-7.6M5
2020--1.1M-2.1M-2.1M2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Martin Roelsgaard Jakobsen joins UNIKUM Therapeutics ApS as directorOct 1, 2024

As of October 1, 2024, Martin Roelsgaard Jakobsen is registered as director of UNIKUM Therapeutics ApS.

Tommi Petteri Kainu steps down as director of UNIKUM Therapeutics ApSSep 30, 2024

As of September 30, 2024, Tommi Petteri Kainu has stepped down as director of UNIKUM Therapeutics ApS.

Stefan Wildt joins the board of UNIKUM Therapeutics ApSAug 12, 2024

As of August 12, 2024, Stefan Wildt has joined the board of directors of UNIKUM Therapeutics ApS.

Johannes Heinrich Frühauf leaves the board of UNIKUM Therapeutics ApSAug 12, 2024

As of August 12, 2024, Johannes Heinrich Frühauf has left the board of directors of UNIKUM Therapeutics ApS.

MR Jakobsen Holding ApS registered as owner of UNIKUM Therapeutics ApSJun 14, 2024

As of June 14, 2024, MR Jakobsen Holding ApS is registered as an owner of UNIKUM Therapeutics ApS with an ownership share of 15%.

UNIKUM Therapeutics ApS: The 2023 annual report is outMar 25, 2024

UNIKUM Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -7,465,410, and the net result was DKK -14,870,759.

BII Holdings A/S registered as owner of UNIKUM Therapeutics ApSMar 20, 2024

As of March 20, 2024, BII Holdings A/S is registered as an owner of UNIKUM Therapeutics ApS with an ownership share of 5%.

Registered as owner of UNIKUM Therapeutics ApSFeb 5, 2024

As of February 5, 2024, is registered as an owner of UNIKUM Therapeutics ApS with an ownership share of 33%.

About UNIKUM Therapeutics ApS

UNIKUM Therapeutics ApS is a Danish company of the type Anpartsselskab based in Risskov, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Roelsgaard Jakobsen. The board consists of Ulrik Bjerl Nielsen (chair), Martin Roelsgaard Jakobsen and Stefan Wildt. The company's owners include MEDIC ADVICE ApS, MR Jakobsen Holding ApS and BII Holdings A/S. The company has 2 employees (2025). In 2025, the company reported a gross profit of DKK -247,887 and a net result of DKK -859,076 compared with DKK -13,797,011 the year before. Equity in the 2025 report amounted to DKK -5,680,033.

Source: annual report 2025, Danish Business Authority

Other financial years